Patent · US Active

Compositions and methods of treating retinal disease

US10913722B2 · kind B2 · utility

15Cited by
31References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 7, 2019
Grant dateFeb 9, 2021
Priority date—
Expiry dateJan 25, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.